tiprankstipranks
Trending News
More News >
10X Genomics (GB:0A88)
:0A88
UK Market

10x Genomics (0A88) Share Forecast & Price Target

Compare
5 Followers
See the Price Targets and Ratings of:

0A88 Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
5 Buy
7 Hold
0 Sell
Based on 12 analysts giving stock ratings to
10x
Genomics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0A88 Stock 12 Month Forecast

Average Price Target

$13.22
▲( 44.32% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for 10x Genomics in the last 3 months. The average price target is $13.22 with a high forecast of $18.00 and a low forecast of $9.00. The average price target represents a 44.32% change from the last price of $9.16.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","36":"$36","14.25":"$14.25","21.5":"$21.5","28.75":"$28.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$13.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$9.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,14.25,21.5,28.75,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.198,8.952,9.706,10.46,11.214,11.968,12.722000000000001,13.476,14.23,14.984,15.738,16.492,17.246000000000002,{"y":18,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.198,8.584307692307693,8.970615384615385,9.356923076923078,9.74323076923077,10.129538461538463,10.515846153846155,10.902153846153848,11.28846153846154,11.674769230769233,12.061076923076925,12.447384615384617,12.833692307692308,{"y":13.22,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.198,8.259692307692308,8.321384615384616,8.383076923076924,8.44476923076923,8.506461538461538,8.568153846153846,8.629846153846154,8.691538461538462,8.75323076923077,8.814923076923076,8.876615384615384,8.938307692307692,{"y":9,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35.725,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.761,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.266,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.478,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.748,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.04,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.598,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.188,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.312,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.09,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.638,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.837,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.198,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$18.00Average Price Target$13.22Lowest Price Target$9.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
$15$11
Hold
20.09%
Upside
Reiterated
05/09/25
Bank of America Securities Analyst forecast on GB:0A88
Michael RyskinBank of America Securities
Bank of America Securities
$12
Hold
31.00%
Upside
Reiterated
05/09/25
J.P. Morgan Analyst forecast on GB:0A88
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
$12$9
Hold
-1.75%
Downside
Reiterated
05/09/25
William Blair Analyst forecast on GB:0A88
Matt LarewWilliam Blair
William Blair
Hold
Reiterated
05/09/25
Barclays Analyst forecast on GB:0A88
Luke SergottBarclays
Barclays
$12
Buy
31.00%
Upside
Reiterated
05/09/25
Stifel Nicolaus Analyst forecast on GB:0A88
Daniel AriasStifel Nicolaus
Stifel Nicolaus
$18$15
Buy
63.76%
Upside
Reiterated
05/09/25
Citi
$20$15
Buy
63.76%
Upside
Reiterated
03/04/25
Guggenheim Analyst forecast on GB:0A88
Subbu NambiGuggenheim
Guggenheim
Hold
Reiterated
02/23/25
Morgan Stanley Analyst forecast on GB:0A88
Tejas SavantMorgan Stanley
Morgan Stanley
$28$26
Buy
183.84%
Upside
Reiterated
02/14/25
Canaccord Genuity Analyst forecast on GB:0A88
Kyle Mikson CFACanaccord Genuity
Canaccord Genuity
$20$18
Buy
96.51%
Upside
Reiterated
02/13/25
UBS
$20$14
Hold
52.84%
Upside
Reiterated
02/13/25
Leerink Partners Analyst forecast on GB:0A88
Puneet SoudaLeerink Partners
Leerink Partners
$25$12
Hold
31.00%
Upside
Downgraded
02/13/25
Jefferies
$19
Buy
107.42%
Upside
Reiterated
02/12/25
Goldman Sachs Analyst forecast on GB:0A88
Matthew SykesGoldman Sachs
Goldman Sachs
$16$14
Sell
52.84%
Upside
Reiterated
10/30/24
Deutsche Bank  Analyst forecast on GB:0A88
Justin BowersDeutsche Bank
Deutsche Bank
$25
Hold
172.93%
Upside
Reiterated
08/09/24
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
$15$11
Hold
20.09%
Upside
Reiterated
05/09/25
Bank of America Securities Analyst forecast on GB:0A88
Michael RyskinBank of America Securities
Bank of America Securities
$12
Hold
31.00%
Upside
Reiterated
05/09/25
J.P. Morgan Analyst forecast on GB:0A88
Rachel VatnsdalJ.P. Morgan
J.P. Morgan
$12$9
Hold
-1.75%
Downside
Reiterated
05/09/25
William Blair Analyst forecast on GB:0A88
Matt LarewWilliam Blair
William Blair
Hold
Reiterated
05/09/25
Barclays Analyst forecast on GB:0A88
Luke SergottBarclays
Barclays
$12
Buy
31.00%
Upside
Reiterated
05/09/25
Stifel Nicolaus Analyst forecast on GB:0A88
Daniel AriasStifel Nicolaus
Stifel Nicolaus
$18$15
Buy
63.76%
Upside
Reiterated
05/09/25
Citi
$20$15
Buy
63.76%
Upside
Reiterated
03/04/25
Guggenheim Analyst forecast on GB:0A88
Subbu NambiGuggenheim
Guggenheim
Hold
Reiterated
02/23/25
Morgan Stanley Analyst forecast on GB:0A88
Tejas SavantMorgan Stanley
Morgan Stanley
$28$26
Buy
183.84%
Upside
Reiterated
02/14/25
Canaccord Genuity Analyst forecast on GB:0A88
Kyle Mikson CFACanaccord Genuity
Canaccord Genuity
$20$18
Buy
96.51%
Upside
Reiterated
02/13/25
UBS
$20$14
Hold
52.84%
Upside
Reiterated
02/13/25
Leerink Partners Analyst forecast on GB:0A88
Puneet SoudaLeerink Partners
Leerink Partners
$25$12
Hold
31.00%
Upside
Downgraded
02/13/25
Jefferies
$19
Buy
107.42%
Upside
Reiterated
02/12/25
Goldman Sachs Analyst forecast on GB:0A88
Matthew SykesGoldman Sachs
Goldman Sachs
$16$14
Sell
52.84%
Upside
Reiterated
10/30/24
Deutsche Bank  Analyst forecast on GB:0A88
Justin BowersDeutsche Bank
Deutsche Bank
$25
Hold
172.93%
Upside
Reiterated
08/09/24
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering 10x Genomics

1 Month
xxx
Success Rate
9/19 ratings generated profit
47%
Average Return
-2.76%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 47.37% of your transactions generating a profit, with an average return of -2.76% per trade.
3 Months
xxx
Success Rate
8/19 ratings generated profit
42%
Average Return
-5.58%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.11% of your transactions generating a profit, with an average return of -5.58% per trade.
1 Year
Success Rate
7/19 ratings generated profit
37%
Average Return
-1.72%
reiterated a buy rating 3 months ago
Copying Patrick B Donnelly's trades and holding each position for 1 Year would result in 36.84% of your transactions generating a profit, with an average return of -1.72% per trade.
2 Years
xxx
Success Rate
3/20 ratings generated profit
15%
Average Return
-39.53%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 15.00% of your transactions generating a profit, with an average return of -39.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0A88 Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
6
6
6
6
2
Buy
10
5
5
3
2
Hold
11
8
8
6
5
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
28
19
19
15
9
In the current month, 0A88 has received 4 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. 0A88 average Analyst price target in the past 3 months is 13.22.
Each month's total comprises the sum of three months' worth of ratings.

0A88 Financial Forecast

0A88 Earnings Forecast

Next quarter’s earnings estimate for 0A88 is -$0.36 with a range of -$0.44 to -$0.26. The previous quarter’s EPS was -$0.28. 0A88 beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.29% of the time in the same period. In the last calendar year 0A88 has Outperformed its overall industry.
Next quarter’s earnings estimate for 0A88 is -$0.36 with a range of -$0.44 to -$0.26. The previous quarter’s EPS was -$0.28. 0A88 beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.29% of the time in the same period. In the last calendar year 0A88 has Outperformed its overall industry.

0A88 Sales Forecast

Next quarter’s sales forecast for 0A88 is $139.34M with a range of $137.79M to $140.90M. The previous quarter’s sales results were $154.88M. 0A88 beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.57% of the time in the same period. In the last calendar year 0A88 has Outperformed its overall industry.
Next quarter’s sales forecast for 0A88 is $139.34M with a range of $137.79M to $140.90M. The previous quarter’s sales results were $154.88M. 0A88 beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.57% of the time in the same period. In the last calendar year 0A88 has Outperformed its overall industry.

0A88 Stock Forecast FAQ

What is GB:0A88’s average 12-month price target, according to analysts?
Based on analyst ratings, 10X Genomics’s 12-month average price target is 13.22.
    What is GB:0A88’s upside potential, based on the analysts’ average price target?
    10X Genomics has 44.32% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is 10X Genomics a Buy, Sell or Hold?
          10X Genomics has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 7 hold ratings and 0 sell ratings.
            What is 10X Genomics’s share price target?
            The average share price target for 10X Genomics is 13.22. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $18.00 ,and the lowest forecast is $9.00. The average share price target represents 44.32% Increase from the current price of $9.16.
              What do analysts say about 10X Genomics?
              10X Genomics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of 10X Genomics?
                To buy shares of GB:0A88, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis